This inventor holds 4 USPTO granted patents. Top assignees: Aventis Behring Gmbh, Csl Behring Gmbh. Active years: 2001-2011.
Location History:
- Seeheim, DE (2001)
- Marburg, DE (2003 - 2011)
Company Filing History:
Years Active: 2001-2011
Title: The Innovative Contributions of Albrecht Groener
Introduction
Albrecht Groener, hailing from Marburg, Germany, is a notable inventor dedicated to the advancement of biotechnology and medicine. With a portfolio of four patents, Groener has made significant strides in the detection and characterization of pathogenic prions, underscoring his commitment to combating serious health threats to humanity.
Latest Patents
Groener's most recent patents involve groundbreaking antibodies designed for the specific detection of pathogenic prions of human origin. These innovative antibodies are engineered to bind to distinctive epitopes found exclusively in human prion proteins, allowing for precise differentiation from prions found in other species such as cows, Syrian Golden hamsters, mice, and rats. The patented methods include a conformation-dependent immunoassay technique that effectively identifies prion proteins exhibiting different conformations. This specificity is crucial, as the PrP protein can exist in distinct conformations, which can notably affect their binding affinity towards the antibodies utilized for their detection.
Career Highlights
Throughout his career, Albrecht Groener has worked with prominent companies in the biotechnology sector, including Aventis Behring GmbH and CSL Behring GmbH. His endeavors in these organizations have provided him with the platform to develop his patented technologies, enhancing disease detection methodologies crucial to public health.
Collaborations
Groener's work has also been influenced by his collaborations with notable colleagues in the field, including Thomas Weimer and Martin Vey. These professional relationships have fostered an environment of knowledge exchange and innovation, accelerating advancements in the field of prion research.
Conclusion
Albrecht Groener's contributions to the detection of pathogenic prions represent a significant milestone in medical research and biotechnology. His work exemplifies the impact of innovative thinking and collaboration in tackling critical health challenges. As the field of prion research evolves, Groener's inventions will continue to play a pivotal role in enhancing our understanding and management of prion-related diseases.